ASC-H (YÜKSEK DERECELİ LEZYONUN DIŞLANAMADIĞI ATİPİK HÜCRE) SİTOLOJİ SONUÇLARININ HİSTOLOJİK OLARAK DEĞERLENDİRİLMESİ
Amaç: Servikal sitolojisinde yüksek dereceli squamöz intraepitelial lezyon dışlanamayan atipik skuamöz hücreler (ASC-H) saptanan hastalarda histolojide servikal intraepitelial lezyon grade ≥2 (≥ CIN 2) tanısının belirleyicilerini ortaya koymaktır. Material ve Metod: 2007- 2015 yıllarında servikal sitoloji sonucu ASC-H olup kolposkopi ile değerlendirilen olgular çalışmaya dahil edildi. Hastaların yaşı, paritesi, menapoz durumu, medeni hali, sigara kullanımı, yüksek riskli human papilloma virüs taşıyıcılığı (hrHPV) ileri doğru regresyon methodu ile analiz edildi. Anlamlılık p <0.05 değerinde hesaplandı. Bulgular: Sitoloji sonucu ASC-H olan 93 hastaya kolposkopik biyopsi yapıldı ve çalışma kapsamında değerlendirildi. Hastaların ortalama yaşı 39.37±1.03 (20-63) olup 32 hasta (% 36.8) sigara kullanmaktaydı. HPV testi 30 hastada yapılmıştı ve 10 hastada (% 33.3) hrHPV tespit edildi. Kolposkopik histoloji tanısı sonucu 44 (% 47.3) hastada normal, 10 (% 10.8), hastada CIN 1, 24 (% 25.8) hastada CIN 2, 12 (% 12.9) hastada CIN 3, 3 hastada da (% 3.2) serviks kanseri tespit edildi. ≥ CIN 2 saptanan hastaların ortalama yaşı (41.13±10.45), ≤ CIN 1 saptanan hastaların ortalama yaşı (36.92±8.61)’ndan yüksekti (p=0.042). HrHPV (+) olan 10 hastadan 9’unda (% 90), buna karşın hrHPV (-) olan 20 hastadan 2’sinde (% 10) ≥ CIN 2 lezyonu olup (p <0.001), sigara kullanan 32 hastadan 18’inde (% 56.2), buna karşın sigara kullanmayan 55 hastadan 18’inde (% 32.7) ≥CIN 2 lezyon tespit edildi (p <0.03). Regresyon analiz sonucucuna göre tek belirleyici (+) hrHPV test olarak bulundu [vs. (-) hrHPVtest; OR 6.351; 95% CI 3.673–8.947, p=0.014]. Sonuç: HPV + olan ASC-H sitolojisine sahip kadınlarda ≥ CIN 2 lezyon riski yüksek olduğundan kolposkopik muayene, biyopsi ve patolojik değerlendirme dikkatli yapılmalıdır
HISTOLOGIC EVALUATION OF ATYPICAL SQUAMOUS CELLS-CANNOT EXCLUDE HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (ASC-H) CYTOLOGY
Aim: To estimate predictors for histological diagnosis of cervical intraepithelial neoplasia of grade ≥2 (≥CIN 2) in patients with atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H) on cervical cytology. Materials and Methods: We retrospectively reviewed the patients with ASC-H who had undergone colposcopic biopsy between the years 2007-2015. Age, parity, menapousal status, marriage status, smoking habitus, high risk Human Papilloma Virus (hrHPV) status were analized with forward likelihood ratio method and significance was set at p <0.05. Results: 93 patients with ASC-H were undergone colposcopy-guided bioopsy. Mean age of the patients was 39.37±1.03 (20-63). HPV test was performed to 30 patients and 10 (33.3 % ) were HR-HPV positive (+). Histologic diagnosis were reported as normal in 44 (47.3 % ), CIN 1 in 10 (10.8 % ), CIN 2 in 24 (25.8 % ), CIN 3 in 12 (12.9 % ) and cervical cancer in 3 (3.2 % ) patients. Mean age of ≥ CIN 2 patients were 41.13±10.45 compared with 36.92±8.61 for ≤ CIN 1 patients (p=0.042). 9 of 10 (90 % ) HR-HPV (+) patients and 18 of 32 (56.2 % ) smokers had ≥ CIN 2 lesions whereas two of 20 (10 % ) HR-HPV negative (-) patients and 18 of 55 (32.7 % ) non-smokers had ≥ CIN 2 lesions (p values were, <0.001 and 0.03 for HR-HPV and smoking status, respectively). According to regression analysis (+) HR-HPV test was the only predictor [vs. (-) HR-HPVtest; OR 6.351; 95% CI 3.673–8.947, p=0.014]. Conclusion: Colposcopic evaluation, biopsy and histological diagnosis should be performed carefully for ASC-H patients, especially if they are HR-HPV positive.
___
- 1. Globocan 2012: Estimated Cancer Incidence, Mortality
and Prevalence worldwide in 2012: http://globocan.iarc.
fr/Default.aspx.
- 2. Ciatto S, Cecchini S, Iossa A, et al. Trends in cervical
cancer incidence in the district of Florence. Eur J Cancer
1995;31A(3):354-5.
- 3. Solomon D, Davrey D, Kurman R, et al. Th e 2001 Bethesda
System: terminology for reporting results of cervical
cytology. JAMA 2002; 287: 2114-9.
- 4. Davey DD, Greenspan DL, Kurtycz DF, Husain M, Austin
RM. Atypical squamous cells, cannot exclude high-grade
squamous intraepithelial lesion: review of ancillary testing
modalities and implications for follow-up. J Low Genit
Tract Dis 2010; 14: 206-14.
- 5. Galliano GE, Moatamed NA, Lee S, Salami N, Apple SK.
Refl ex high risk HPV testing in atypical squamous cells,
cannot exclude high grade intraepithelial lesion: a large
institution’s experience with the significance of this oft en
ordered test. Acta Cytol 2011;55:167–172
- 6. Mokhtar GA, Delatour NL, Assiri AH, Gilliatt MA, Senterman
M, Islam S. Atypical squamous cells, cannot exclude
high- grade squamous intraepithelial lesion: cytohistologic
correlation study with diagnostic pitfalls. Acta
Cytol 2008;52:169–177
- 7. McHale MT, Souther J, Elkas JC, Monk BJ, Harrison TA
(2007) Is atypical squamous cells that cannot exclude
high-grade squa- mous intraepithelial lesion clinically
significant? J Low Genit Tract Dis 11:86–89
- 8. Gilani SM, Tashjian R, Fathallah L. Cervical cytology
wiyh a diagnosis of atypical cells, cannot exclude highgrade
squamous intraepithelial lesion (ASC-H): a followup
study with corresponding histology and significance
of predicting dysplasia by human papillomavirus (HPV)
DNA testing. Arch Gynecol Obstet 2014; 289: 645-8.
- 9. Massad LS, Einstein MH, Huh WK, et al. 2012 updated
consensus guidelines for the management of abnormal
cervical cancer screening tests and cancer precursors. J
Low Genit Tract Dis. 2013; 17:S1–S27.
- 10. Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM. Refl ex
high-risk human papilloma virus DNA test is useful in
the triage of women with atypical squamous cells cannot
exclude high-grade squamous intraepithelial lesion. Diagn
Cytopathol. 2006; 34:707–10.
- 11. Reid-Nicholson M, Gatscha RM, Riedel ER, Lin O. Atypical
squamous cells, cannot exclude high grade intraepithelial
lesion (ASC-H): Does HPV matter? Diagn Cytopathol
2007; 35:1–5.
- 12. Liman AK, Giampoli EJ, Bonfiglio TA. Should women
with atypical squamous cells, cannot exclude high-grade
squamous intraepithelial lesion, receive refl ex human
papillomavirus-DNA testing? Cancer 2005; 105:457–60.
- 13. Xu L, Verdoodt F, Wentzensen N, Bergeron C, Arbyn
M. Triage of ASC-H: a meta-analysis of the accuracy of
hrHPV testing and other markers to detect cervical precancer.
Cancer Cytopathol 2016; 124(4):261-272.
- 14. Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N. Atypical
squamous cells, cannot exclude a high-grade intraepithe-
lial lesion and its clinical significance in postmenopausal,
pregnant, postpartum, and contraceptive-use
patients. Cancer 2008; 114:481–488.